Tag: Atlantic PATH

Data NB

Posted on by pathwp

Our colleagues and administrative data holders in New Brunswick have rebranded to DataNB (formerly NB Institute for Research, Data and Training). “We have become synonymous with data – whether it’s training data analysts, holding provincial data or providing data access for research – so the name change just made sense,” said founding director Dr. Ted McDonald, a member of Health Data Research Network Canada’s Executive Committee. For the full announcement, please visit here. In 2024, a collaboration between Atlantic PATH and DataNB created a data linkage that made predicting chronic disease faster and simpler. “I am absolutely thrilled to see these linkages happen,” said Dr. Robin Urquhart, Atlantic PATH Scientific Director. “Atlantic PATH is an incredibly rich resource to understand the health of Atlantic Canadians and all of the different factors, like our biology, behaviours, and environments, that impact our health. This new linkage activity makes our resource more powerful, giving us access to different sources of data to answer complex health questions affecting all AtlanticCanadians.” “Not only is this historical, record-level data linkage activity, this work is crucial for Atlantic Canada, which has among the country’s highest rates of chronic disease and cancer,” said Dr. McDonald “Critically, it will enable researchers to focus on studies related to cancer and chronic disease that cannot be undertaken without linking the separate data sources. The data linkage has other important implications too, such as the potential to inform health policy and improve detection, prevention and treatment.” For additional information about data access, Atlantic PATH and DataNB, please reach out to us directly.

Participant Town Hall

Posted on by pathwp

Join us for the upcoming Atlantic PATH and CanPath Participant Town Hall! On Monday, November 17th, you can learn about how we are “Preventing Cancer, Together: How your Data is Driving Discoveries.” The Canadian Partnership for Tomorrow’s Health (CanPath) is the largest population health study in Canada with more than 330,000 participants in seven regional cohorts, including Atlantic PATH, BC Generations Project, Alberta’s Tomorrow Project, Healthy Future Sask, Manitoba Tomorrow Project, Ontario Health Study, and CARTaGENE (Quebec). The data and biological samples provided by our participants are used to study cancer and chronic disease and support exciting scientific discoveries. Join us at the Town Hall to When: Monday, November 17, 2025 1-230pm Atlantic Time Where: Online Zoom Meeting Register here and submit your questions to be answered during our panel discussion. Please note, the webinar will be recorded and shared afterwards on YouTube.

World Mental Health Day

Posted on by pathwp

Join us in recognizing World Mental Health Day. CanPath is Canada’s largest population health study and includes approximately 34,000 participants who were diagnosed with depression and more than 27,000 participants with anxiety. Data and biosamples provided by our participants are being used in critical mental health research. Alexandra Del Favero is a PhD student in the Department of Earth and Environmental Studies at Dalhousie University. Along with her supervisor, Dr. Kelvin Fong and using questionnaire data, toenail and saliva samples from Atlantic PATH, Alex is examining the effect of environmental factors on mental health in Nova Scotia. CanPath is one of 23 cohorts with 2.8 million participants included in the COVID Global Mental Health Consortium (CGMHC). Led by Dr. Jordan Smoller (Harvard University, Massachusetts General Hospital), this work is investigating pandemic-related mental health outcomes using individual-level harmonized longitudinal data. Data collected from CanPath COVID-19 questionnaires completed by participants from all regional cohorts are being used. Atlantic PATH are proud to lead this work on behalf of CanPath. Dr. Ashlyn Swift-Gallant (Department of Psychology, Memorial University) used data from Atlantic PATH to conduct research that found ovarian hormones contribute to the sex disparity in post-traumatic stress disorder. Drs. Gabriela Ilie, Rob Rutledge and Ellen Sweeney (Dalhousie University and Nova Scotia Health) used data from Atlantic PATH to investigate the association between prostate cancer diagnosis and mental health outcomes. Their work found increased rates of anxiety and depression among males with a history of prostate cancer; higher odds of depression among prostate cancer survivors who were treated with surgery; and higher rates of depression among prostate cancer survivors with a low household income compared to other forms of cancer and a high household income. These findings highlight the importance of a multidisciplinary effort to prioritize and deliver comprehensive mental health support to prostate cancer survivors. This work has helped to inform the groundbreaking Prostate Cancer Patient Empowerment Program (PC-PEP) and CancerPEP led by Drs. Ilie and Rutledge that have been implemented around the world. Atlantic PATH is one of the 18 cohort studies in the PSYchosocial factors and CAncer (PSY-CA) Consortium. Led by Dr. Joost Dekker from the Amsterdam University Medical Centre, this study investigated whether psychosocial factors, such as depression can predict the incidence of cancer. Multiple publications that include Atlantic PATH data can be found here. To find out about the most up-to-date mental health research and learn about data access, please visit our website.

Message from the Minister of Health – Breast Cancer Awareness Month

Posted on by pathwp

From: Public Health Agency of Canada Statement from the Minister of Health, The Honourable Marjorie Michel P.C., M.P. October 8, 2025  | Ottawa, Ontario | Public Health Agency of Canada “Breast cancer remains one of the most common forms of cancer and the second leading cause of cancer-related death among women in Canada. One in eight women will receive a breast cancer diagnosis in their lifetime.  That’s why the Government of Canada works closely with partners and stakeholders to promote breast cancer awareness, prevention and screening for early detection. Empowering women to make informed decisions about their health can save lives. …Important work is happening to help us better understand breast cancer trends and risks to better respond to the diverse needs of women across Canada. For example, we have partnered with the Canadian Partnership for Tomorrow’s Health and Statistics Canada to accelerate breast cancer data analysis based on factors such as age, race and ethnicity. As well, experts are enhancing the OncoSim-Breast model that was developed by the Canadian Partnership Against Cancer and Statistics Canada, by including data on breast density and exploring the inclusion of race-based data to better predict breast cancer outcomes and inform decision making. Breast cancer touches the lives of so many every day. Nobody should have to face this disease alone. If you or a loved one is coping with a cancer diagnosis, there are many ways you can seek support. Visit the Canadian Cancer Society’s community services locator, which helps cancer patients, caregivers and health care providers find the services they need.”

IPAJC at EPICOH

Posted on by pathwp

The International Partnership on Automatic Job Coding (IPAJC) will be represented at the 30th edition of the EPICOH Conference (Epidemiology in Occupational Health) from October 6-9, 2025 in Utrecht, the Netherlands. The IPAJC was established in 2021 with the partnership seeking to enable and promote efficient collection, processing, and accessibility of job information through improvement of automatic coding tools. Involvement and participation in IPAJC includes occupational epidemiologists and computer scientists engaged in examining the relationships between occupational exposures and health, and has since been expanded to include economists, statisticians and sociologists. Our Research Director, Dr. Ellen Sweeney is a member of the leadership team and represents Atlantic PATH and CanPath. The IPAJC will present at EPICOH: Calvin Ge, Peter Elias, Melissa C. Friesen, Olga Kononykhina, Stacey Marovich, Cheryl Peters, Daniel E. Russ, Malte Schierholz, Ellen Sweeney, Anil Adisesh. (2025). The International Partnership on Automatic Job Coding (IPAJC): A Hub for Automatic Job Coding and Industry Coding Tools and Expertise for Occupational Health Research. Poster Presentation. EPICOH. Utrecht, Netherlands. Additional member presentations include: Daniel E. Russ. (2025). Small Language Model Based NAICS 2022 CLassification of Industry from Products and Services: CLIPS. Oral Presentation. EPICOH. Utrecht, Netherlands. Calvin Ge. (2025). TNO-Auto Occupation Coder: A Novel, Large-Language Model Based Multilingual Automatic Coding Tool for Occupations. Oral Presentation. EPICOH. Utrecht, Netherlands. Pabitra Jossee. (2025). Using the SOCcer occupation auto-coding tool to help participants self-code their occupation in online questionnaires. Oral Presentation. EPICOH. Utrecht, Netherlands. IPAJC hosts bi-monthly online meetings to discuss topics and advances related to automatic classification of jobs, industries, skills and related information. See our upcoming meetings and connect on our LinkedIn page, or contact us for more information.

Atlantic PATH – Prostate Cancer Awareness Month

Posted on by pathwp

To round up Prostate Cancer Awareness Month, we are highlighting some of the recent and ongoing work on prostate cancer conducted using Atlantic PATH data and biosamples. Flashback to 2023 and welcoming our youngest team member(!) and the Plaid for Dad tradition raising awareness about prostate cancer in Canada. We have ongoing research on prostate cancer exploring environmental exposure to arsenic and cancer risk using toxicological and machine learning methods. This research stream has received and benefitted from funding from Nova Scotia Health, the Beatrice Hunter Cancer Research Institute, Prostate Cancer Canada, the Canadian Cancer Society, and the New Frontiers in Research Fund. Watch this space for new findings and publications! Related publications to date include: Majouni, S., Kim, J.S., Sweeney, E., Keltie, E., Abidi, S. (2022). Applying Machine Learning to Arsenic Species and Metallomics Profiles of Toenails to Evaluate Associations of Environmental Arsenic with Incident Cancer Cases. Medical Informatics Europe Conference (MIE) Conference Proceedings. Studies in Health Technology and Informatics. Keltie, E., Hood, K., Cui, Y., Sweeney, E., Ilie, G., Adisesh, A., Dummer, T.J.B., Bharti, V., Kim, J.S. (2022). Arsenic speciation and metallomics profiling of human toenails as a biomarker to assess prostate cancer cases: Atlantic PATH cohort study. Frontiers in Public Health, 10.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301242/ Hood, K., Sweeney, E., Ilie, G., Keltie, E., Kim, J.S. (2023). Toenail arsenic species and metallome profiles associated with breast, cervical, prostate, and skin cancer prevalence in the Atlantic Partnership for Tomorrow’s Health cohort. Frontiers in Public Health, Environmental Health and Exposome.  https://www.frontiersin.org/articles/10.3389/fpubh.2023.1148283/full Smith, N., Keltie, E., Sweeney, E., Weerasinghe, S., MacPherson, K., Kim, J.S. (2022). Toenail speciation biomarkers in arsenic-releated disease: a feasibility study for investigating the association between arsenic expsosure and chronic disease. Ecotoxicology and Environmental Safety, 232. https://www.sciencedirect.com/science/article/pii/S0147651322001099 The Langille Lab at Dalhousie University has an ongoing research stream on the microbiome. This work has included a focus on prostate cancer. Related publications include: Nearing, J., DeClercq, V., Langille, M. (2023). Investigating the Oral Microbiome in Retrospective and Prospective Cases of Prostate, Colon and Breast Cancer. Nature Biofilms and Microbiomes. https://www.nature.com/articles/s41522-023-00391-7. We have also conducted research on the mental health of prostate cancer survivors compared to those with no history of cancer and those with types of cancer. This work was supported by funding from the Beatrice Hunter Cancer Research Institute. Publications to date include: Ilie, G., Rutledge, R., Sweeney, E. (2020). Anxiety and depression symptoms in adult males in Atlantic Canada with or without a lifetime history of prostate cancer. Psycho-Oncology. https://onlinelibrary.wiley.com/doi/10.1002/pon.5244 Ilie, G., Rutledge, R., Sweeney, E. (2021). An examination of the role of socioeconomic status in the relationship between depression and prostate cancer survivorship in a population-based sample of men from Atlantic Canada. Oncology, 99(4). https://pubmed.ncbi.nlm.nih.gov/33486485/ Ilie, G., Rutledge, R., Sweeney, E. (2021). Post-Treatment Adverse Health Correlates among Prostate Cancer Survivors in a Sample of Men Residing in Atlantic Canada. Current Oncology, 28(4). https://www.mdpi.com/1718-7729/28/4/246

CanPath Round Up: Prostate Cancer Awareness Month

Posted on by pathwp

What could you uncover with data from over 3,500 participants with prostate cancer? 🤔💭 With close to 3,000 prevalent cases of prostate cancer within our participant population, CanPath remains committed to continuing to support participants and researchers in uncovering new breakthroughs in prostate cancer prevention, detection and treatment. By collecting biological, genetic and health data from our participants, we can keep track of new and existing cases of prostate cancer to provide researchers with access to invaluable health information to support the next generation of cancer research. 🔗 Get inspired by the latest prostate cancer publications using CanPath data: http://bit.ly/46VMeqJ

Government of Canada invests in research to strengthen pandemic preparedness and response

Posted on by pathwp

Read how CanPath, Canada’s largest health research study is ready to respond News release September 23, 2025 – Ottawa, Ontario – Canadian Institutes of Health Research “As we begin respiratory infectious diseases season, the Government of Canada is investing in critical research infrastructure to ensure that public health and immunization programs are as effective as they can be in protecting the health of Canadians and that Canada is ready for future pandemics and public health emergencies. Today, the Honourable Marjorie Michel, Minister of Health, announced an investment of nearly $20 million through the CIHR Centre for Research on Pandemic Preparedness and Health Emergencies and partners to support seven research platforms that unite researchers from all across the country to maintain Canada’s pandemic readiness, improve surveillance systems, and support evidence-based decision-making. These platforms will strengthen Canada’s capacity to detect, monitor, and respond to emerging infectious diseases, while addressing the social, behavioural, and health system challenges that arise during pandemics and other health emergencies. Broadly, the research teams will: These investments support the Government of Canada’s ongoing efforts to strengthen pandemic preparedness and protect the health of Canadians and the international community.” Quotes “The COVID-19 pandemic taught us the importance of being ready for the unexpected. These research investments will strengthen innovative science and collaboration across the country—helping Canada be better equipped to respond quickly and effectively to future public health emergencies.” —The Honourable Marjorie Michel, Minister of Health “These initiatives reflect the best of Canadian research, with a focus on real-world impact. Our scientists continue to provide the important evidence and maintain the research infrastructure that all Canadians rely on to prevent, prepare for, and respond to future health emergencies.” — Dr. Paul Hébert, President, Canadian Institutes of Health Research Quick facts

CanPath awarded $3M to study crises in a changing world

Posted on by pathwp

Read the original news release from the Government of Canada Toronto, Canada, September 23, 2025 – What if Canada had a research platform ready to track the next pandemic, study the effects of climate change on health, and help explain rising cancer rates in young people? With a $3 million grant from the Canadian Institutes of Health Research (CIHR), CanPath is that platform. Awarded through CIHR’s Pandemic Research Platforms Interim Funding opportunity, this two-year operating grant supports CanPath’s unique ability to generate fast, meaningful insights during public health emergencies. This work goes far beyond pandemics: it also aims to tackle broader crises like climate-related health risks and early-onset cancer. “This grant strengthens CanPath’s ability to respond quickly and effectively to future public health emergencies,” said Dr. Jennifer Brooks, CanPath’s Executive Director. “Our platform is built for this kind of work, with hundreds of thousands of Canadians already engaged, linked health records, and long-term follow-up in place.” The grant is led by Dr. Brooks and Dr. Philip Awadalla, CanPath’s National Scientific Co-Director, with a national team of co-investigators. The funding is held at the Dalla Lana School of Public Health, University of Toronto. “CanPath is known as a research resource, but now in its prime, it’s built for resilience,” said Dr. Awadalla. “We’re proud to continue this work with our partners and support Canada’s preparedness for emerging diseases in a changing world.” Canada’s largest health study is ready to respond CanPath, the Canadian Partnership for Tomorrow’s Health, is the country’s largest population health cohort, with more than 330,000 participants recruited from all 10 provinces. Participants have consented to long-term follow-up, data linkage, and future contact, providing a uniquely flexible and future-ready research platform. During the COVID-19 pandemic, CanPath rapidly deployed a national antibody study, linked testing data to participant records, and surveyed participants in real time. Results were shared widely with researchers, policymakers, and the public and featured by Global News, National Post, and The Globe and Mail. “CanPath’s COVID-19 response showed how powerful our model can be,” said Dr. Victoria Kirsh, CanPath National Scientific Coordinator. “We were able to launch surveys, test for antibodies, and communicate directly with participants in record time. This grant ensures we can build on that success, strengthen our partnerships, and stay ready to support evidence-based action when it matters most.” What this funding supports Through this grant, CanPath will continue to: This work builds on CanPath’s strategic partnerships with: Together, these partnerships strengthen CanPath’s role as a responsive, data-rich platform that serves researchers, funders, policymakers, and communities alike. Ready for the next challenge This grant builds on CanPath’s proven ability to act fast, scale up, and generate real-world impact. In future public health emergencies, CanPath is ready to: CanPath’s national team of investigators—including Drs. Trevor Dummer, Simon Gravel, Vikki Ho, Victoria Kirsh, Guillaume Lettre, Grace Shen-Tu, Jared Simpson, Ellen Sweeney, Megan Vanstone, Donna Turner, and Robin Urquhart—brings deep expertise across research fields and geographies. “This isn’t just about the next pandemic,” said Brooks. “It’s about being prepared for the full range of health challenges we’re facing, from chronic diseases—including cancer—to environmental change. This grant helps us keep Canada at the forefront of evidence-based, equitable research.” Pandemics don’t wait, and thanks to this investment, neither will CanPath. For more information, please contact:Megan FlemingCommunications & Knowledge Translation OfficerCanadian Partnership for Tomorrow’s Health (CanPath)info@canpath.ca

Arthritis Awareness Month

Posted on by pathwp

Please join Atlantic PATH in acknowledging Arthritis Awareness Month this September. Arthritis affects joints and other tissues which results in pain and limited mobility. One in five people in Canada live with arthritis and Atlantic Canada has some of the highest rates in the country. We would like to highlight arthritis research using data from Atlantic PATH participants. Dr. Cheryl Kozey and colleagues completed a study on the Current Management and Health Care Quality for Patients with Hip and Knee Osteoarthritis. The team used existing data from Atlantic PATH to examine self-reported characteristics of people living with and without osteoarthritis in all three Maritime Provinces (New Brunswick, Nova Scotia and Prince Edward Island).  The Atlantic PATH data for Nova Scotians was then linked to administrative data, accessed through Health Data Nova Scotia, in order to identify trends in health care use by Nova Scotians with and without osteoarthritis. The report, Current Management and Health Care Use for People with Osteoarthritis and infographic detail their findings, including that people with osteoarthritis in the Maritimes were older, more likely to be female, and had lower socioeconomic status compared to those without osteoarthritis. Participants with osteoarthritis from Atlantic PATH were invited to participate in an ancillary study. The article “Quality of Non-Surgical and Non-Pharmacological Knee Osteoarthritis Care in the Maritimes” highlights that more than half of individuals with mild-to-moderate knee osteoarthritis did not receive recommended core treatments in the Maritimes, highlighting a need to improve care for this patient group. Dr. Vanessa DeClercq‘s work focused on the relationship between adipokines and adiposity among females with rheumatoid and osteoarthritis. Using data and biological samples from Atlantic PATH, they found that those with higher levels of adiponectin were more likely to have osteoarthritis, but not rheumatoid arthritis. This study demonstrates differences in measures of adiposity and adipokines in specific types of arthritis.